Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study of pembrolizumab, alone or with chemotherapy, for recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma. It also provides participant criteria, outcome measures, publications, and study documents.
    Difference
    63%
    Check dated 2026-11-08T11:25:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-11-01T12:20:58.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T12:27:25.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:34:38.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T12:59:41.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record. This makes the study details and navigation inaccessible to users.
    Difference
    21%
    Check dated 2026-09-20T04:51:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.